MLH1 and colorectal cancer: In colorectal cancer, the MLH1-/PMS2- pattern was observed in 81.1% of the cases, followed by MSH2-/MSH6- (10.8%), MSH6-/PMS2- (5.4%), and PMS2- (2.7%).